ASR Vermogensbeheer’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.3M Sell
275,102
-3,835
-1% -$449K 0.36% 50
2026
Q1
$33.6M Buy
278,937
+5,059
+2% +$584K 0.39% 55
2025
Q4
$28.8M Sell
273,878
-2,384
-0.9% -$224K 0.34% 68
2025
Q3
$23.2M Sell
276,262
-1,094
-0.4% -$90.1K 0.28% 75
2025
Q2
$22M Sell
277,356
-449
-0.2% -$35.7K 0.28% 75
2025
Q1
$24.9M Buy
+277,805
New +$25.9M 0.37% 58

Other funds holding MRK

ASR Vermogensbeheer's MRK Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $449K and leaving 275,102 shares worth $35.3M. The position accounts for 0.36% of the portfolio, ranked #50.

ASR Vermogensbeheer first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • ASR Vermogensbeheer held 275,102 shares of Merck worth $35.3M as of Q2 2026.
  • ASR Vermogensbeheer sold 3,835 Merck shares in Q2 2026, an estimated $449K.
  • Merck made up 0.36% of ASR Vermogensbeheer's portfolio in Q2 2026, its #50 holding.
  • ASR Vermogensbeheer first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.